Pages that link to "Q53682776"
Jump to navigation
Jump to search
The following pages link to Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma. (Q53682776):
Displaying 6 items.
- Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma (Q60922130) (← links)
- TINAGL1 promotes hepatocellular carcinogenesis through the activation of TGF-β signaling-medicated VEGF expression (Q61448005) (← links)
- MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1 (Q61449576) (← links)
- Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo (Q89468280) (← links)
- miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells (Q91151354) (← links)
- Therapeutic Ultrasound Parameter Optimization for Drug Delivery Applied to a Murine Model of Hepatocellular Carcinoma (Q101377881) (← links)